Experienced in Mesenchymoma

Alessandra Fabi

Rome, IT 
Experienced in Mesenchymoma
Rome, IT 
OverviewLocationsClinical Research

Overview

Alessandra Fabi practices in Rome, Italy. Ms. Fabi is rated as an Experienced expert by MediFind in the treatment of Mesenchymoma. Her top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Agranulocytosis, Mastectomy, and Vertebroplasty.

Her clinical research consists of co-authoring 323 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Mesenchymoma.

Gender
Female

Locations

Rome, Italy
Other Locations
Milan, 20133, Italy
Gravedona-san Gregorio, Italy
Bologna, Italy
Viterbo, 01100, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized, Double-blind, Placebo-controlled Adjuvant Trial in Newly Diagnosed Primary Glioblastoma Subjects to Assess the Efficacy and Safety of LAM561 in Combination With Radiotherapy and Temozolomide Standard of Care Treatment.
A Randomized, Double-blind, Placebo-controlled Adjuvant Trial in Newly Diagnosed Primary Glioblastoma Subjects to Assess the Efficacy and Safety of LAM561 in Combination With Radiotherapy and Temozolomide Standard of Care Treatment.
Enrollment Status: Active_not_recruiting
Publish Date: November 20, 2025
Intervention Type: Radiation, Drug
Study Drugs: 2-hydroxyoleic Acid, Temozolomide
Study Phase: Phase 2/Phase 3
Atezolizumab, Pertuzumab and Trastuzumab With Chemotherapy as Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer (APTneo)
Atezolizumab, Pertuzumab and Trastuzumab With Chemotherapy as Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer (APTneo)
Enrollment Status: Active_not_recruiting
Publish Date: March 06, 2024
Intervention Type: Drug, Procedure
Study Drugs: Trastuzumab, Pertuzumab, Carboplatin, Paclitaxel, Doxorubicin, Cyclophosphamide, Atezolizumab
Study Phase: Phase 3
A Phase II Trial of Atezolizumab Plus CArboplatin Plus Nab-paclitaxel as First-line Therapy in Metastatic Triple-negative PD-L1 Positive Breast Cancer Patients - the GIM25-CAPT Trial
A Phase II Trial of Atezolizumab Plus CArboplatin Plus Nab-paclitaxel as First-line Therapy in Metastatic Triple-negative PD-L1 Positive Breast Cancer Patients - the GIM25-CAPT Trial
Enrollment Status: Active_not_recruiting
Publish Date: February 01, 2024
Intervention Type: Combination product
Study Drugs: Atezolizumab, Paclitaxel, Carboplatin
Study Phase: Phase 2
Multicenter, Randomized, Phase II Study of Neoadjuvant Chemotherapy Associated or Not With Zoledronate and Atorvastatin in Triple Negative Breast Cancers - YAPPETIZER Study
Multicenter, Randomized, Phase II Study of Neoadjuvant Chemotherapy Associated or Not With Zoledronate and Atorvastatin in Triple Negative Breast Cancers - YAPPETIZER Study
Enrollment Status: Completed
Publish Date: October 19, 2023
Intervention Type: Drug
Study Drugs: Zoledronate, Atorvastatin, Standard neoadjuvant chemotherapy
Study Phase: Phase 2
View 3 Less Clinical Trials

323 Total Publications

Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer.
Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer.
Journal: The New England journal of medicine
Published: October 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Fabi's expertise for a condition
ConditionClose
    View All 24 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile